Continuing in the discussion of the important role of NF-κB as an anti-tumor pathway, a recent study demonstrated that NF-κB-inducing kinase (NIK), which is known to be a mediator of noncanonical NF-κB activation, is a pivotal regulator of T cell metabolism and antitumor immunity [94]. This evidence concerns the gene NFKB1 and neoplasm.